If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

More states are loosening vaccine mandates, scaling back vaccine promotion efforts and taking other steps likely to lower ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...

Just weeks after being sworn into her role as U.S. Agriculture Secretary, Brooke Rollins is focusing on battling the spread ...

If the FDA and CDC sit on their hands, next season the flu shot will be a lot more expensive, if you can find it at all. That ...

Public health experts say they are on edge about the upcoming influenza vaccine after the Food and Drug Administration canceled a routine advisory meeting last week.

Now the Johns Hopkins University surgeon and researcher has been nominated to lead the FDA. The agency -- responsible for ...

BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...

The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s efforts to develop a RNA-based vaccine for ...